Tomoya Watanabe

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Progressive Ocular Involvement in Toxic Epidermal Necrolysis Despite Early and Intensive Multidisciplinary Management: A Case Report.

Progressive Ocular Involvement in Toxic Epidermal Necrolysis Despite Early and Intensive Multidisciplinary Management: A Case Report.

Journal: The Journal of dermatology

Published: February 26, 2026

Risk Factors for Cutaneous Immune-Related Adverse Events in the Japanese Population: A Retrospective Single-Center Cohort Study.

Risk Factors for Cutaneous Immune-Related Adverse Events in the Japanese Population: A Retrospective Single-Center Cohort Study.

Journal: The Journal of dermatology

Published: February 02, 2026

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study.

Journal: Annals of the rheumatic diseases

Published: October 27, 2025

Regional differences in clinical manifestations of antisynthetase syndrome: a comparison between Asian and European cohorts.

Regional differences in clinical manifestations of antisynthetase syndrome: a comparison between Asian and European cohorts.

Journal: Arthritis research & therapy

Published: October 05, 2025

Predictors of Immunosuppressive Treatment in Cutaneous Arteritis: Analysis of Clinical Characteristics in 42 Patients.

Predictors of Immunosuppressive Treatment in Cutaneous Arteritis: Analysis of Clinical Characteristics in 42 Patients.

Journal: The Journal of dermatology

Published: September 23, 2025

A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast.

A Case of Bullous Pemphigoid Coexisted With Psoriasis Vulgaris Successfully Treated by Apremilast.

Journal: The Journal of dermatology

Published: July 03, 2025

Successful re-administration of tocilizumab in a patient with adult-onset Still's disease after improvement of macrophage activation syndrome.

Successful re-administration of tocilizumab in a patient with adult-onset Still's disease after improvement of macrophage activation syndrome.

Journal: Modern rheumatology case reports

Published: January 04, 2025

Author reply to "regarding "retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis"".

Author reply to "regarding "retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis"".

Journal: The Journal of dermatology

Published: August 06, 2024

Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.

Journal: Rheumatology (Oxford, England)

Published: July 11, 2024

A water-soluble caveolin-1 peptide inhibits psoriasis-like skin inflammation by suppressing cytokine production and angiogenesis.

A water-soluble caveolin-1 peptide inhibits psoriasis-like skin inflammation by suppressing cytokine production and angiogenesis.

Journal: Scientific reports

Published: April 06, 2024

Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.

Retrospective study of the clinical significance of the neutrophil-to-lymphocyte ratio in 79 patients with palmoplantar pustulosis.

Journal: The Journal of dermatology

Published: March 06, 2024

Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.

Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.

Journal: Arthritis research & therapy

Published: January 11, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026